{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:47:58Z","timestamp":1757310478465},"reference-count":19,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vaccine.2017.04.038","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T00:01:25Z","timestamp":1493856085000},"page":"5449-5453","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Global polio eradication: Where are we in Europe and what next?"],"prefix":"10.1016","volume":"36","author":[{"given":"Lucia Pastore","family":"Celentano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma","family":"Carrillo-Santisteve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Danielsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Huseynov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarik","family":"Derrough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam","family":"Adel Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robb","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donato","family":"Greco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.04.038_b0005","unstructured":"World Health Organization. Polio weekly update 04\/january\/ 2017. http:\/\/polioeradication.org\/polio-today\/polio-now\/this-week\/."},{"issue":"July","key":"10.1016\/j.vaccine.2017.04.038_b0010","first-page":"2015","article-title":"Polio eradication endgame midterm","author":"World Health Organization","year":"2015","journal-title":"Review"},{"key":"10.1016\/j.vaccine.2017.04.038_b0015","unstructured":"World Health Organization. WHO Guidance for implementation of the IHR Temporary Recommendations under the IHR (2005) to reduce the international spread of polio; 16 May 2014. http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Emergency\/PolioPHEICguidance.pdf."},{"issue":"6","key":"10.1016\/j.vaccine.2017.04.038_b0020","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1539-6924.2006.00844.x","article-title":"Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management","volume":"26","author":"Dowdle","year":"2006","journal-title":"Risk Anal"},{"issue":"25","key":"10.1016\/j.vaccine.2017.04.038_b0025","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa0910074","article-title":"Implications of a circulating vaccine-derived poliovirus in Nigeria","volume":"362","author":"Jenkins","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.04.038_b0030","unstructured":"WHO GPEI Reporting and classification of vaccine-derived polioviruses. http:\/\/polioeradication.org\/tools-and-library\/resources-for-polio-eradicators\/gpei-tools-protocols-and-guidelines\/."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.04.038_b0035","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1093\/infdis\/jit845","article-title":"Modeling the dynamics of oral poliovirus vaccine cessation","volume":"210","author":"Thompson","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.038_b0040","unstructured":"GPEI WHO Standard operating procedures: responding to a poliovirus event and outbreak, part 1: general SOPs; 15 Aug 2016. http:\/\/polioeradication.org\/tools-and-library\/resources-for-polio-eradicators\/gpei-tools-protocols-and-guidelines\/."},{"key":"10.1016\/j.vaccine.2017.04.038_b0045","unstructured":"GPEI WHO Standard operating procedures: responding to a poliovirus event and outbreak, part 2: protocol for poliovirus type 2; 15 Aug 2016. http:\/\/polioeradication.org\/tools-and-library\/resources-for-polio-eradicators\/gpei-tools-protocols-and-guidelines\/."},{"key":"10.1016\/j.vaccine.2017.04.038_b0050","series-title":"Wild-type poliovirus 1 transmission in Israel \u2013 what is the risk to the EU\/EEA?","author":"European Centre for Disease Prevention and Control","year":"2013"},{"key":"10.1016\/j.vaccine.2017.04.038_b0055","unstructured":"WHO CISID; 2016. http:\/\/data.euro.who.int\/CISID\/."},{"key":"10.1016\/j.vaccine.2017.04.038_b0060","unstructured":"World Health Organization. Fifteenth meeting of the European regional commission for the certification of poliomyelitis eradication, Copenhagen; 19\u201321 June 2002. http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0003\/79374\/E88105.pdf."},{"key":"10.1016\/j.vaccine.2017.04.038_b0065","first-page":"21","article-title":"Lesson learnt to keep Europe polio free","volume":"2016","author":"Derrough","year":"2016","journal-title":"Eurosurveillance"},{"issue":"3","key":"10.1016\/j.vaccine.2017.04.038_b0070","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/eurpub\/ckw023","article-title":"Public health needs of migrants, refugees and asylum seekers in Europe, 2015: infectious disease aspects","volume":"26","author":"Semenza","year":"2016","journal-title":"Eur J Public Health"},{"issue":"10","key":"10.1016\/j.vaccine.2017.04.038_b0075","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S1473-3099(15)00064-X","article-title":"The Israeli public health response to wild poliovirus importation","volume":"15","author":"Kaliner","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.038_b0080","unstructured":"Herriman Robert. Belgium: Live polio virus solution accidentally released into local water, Outbreak news today; September 12, 2014. http:\/\/outbreaknewstoday.com\/belgium-live-polio-virus-solution-accidentally-released-into-local-water-59622\/."},{"key":"10.1016\/j.vaccine.2017.04.038_b0085","unstructured":"WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use WHO\/POLIO\/15.05. http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/12\/GAPIII_2014.pdf."},{"key":"10.1016\/j.vaccine.2017.04.038_b0090","unstructured":"EU \u201cScience in society\u201d research framework ASSET project. http:\/\/www.asset-scienceinsociety.eu\/."},{"key":"10.1016\/j.vaccine.2017.04.038_b0095","series-title":"Modeling the interplay between human behavior and the spread of infectious diseases","year":"2013"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T14:47:20Z","timestamp":1534517240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17305169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":19,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0264410X17305169"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global polio eradication: Where are we in Europe and what next?","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}